Loading...
PBF509, an Adenosine A(2A) Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders
Adenosine A(2A) receptor (A(2A)R) antagonists have emerged as complementary non-dopaminergic drugs to alleviate Parkinson’s disease (PD) symptomatology. Here, we characterize a novel non-xhantine non-furan A(2A)R antagonist, PBF509, as a potential pro-dopaminergic drug for PD management. First, PBF5...
Na minha lista:
| Udgivet i: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202948/ https://ncbi.nlm.nih.gov/pubmed/30405415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01200 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|